Literature DB >> 9226957

Cloning of peroxiredoxin, a novel antioxidant enzyme, from the helminth parasite Fasciola hepatica.

S McGonigle1, G P Curley, J P Dalton.   

Abstract

A cDNA was isolated from a cDNA expression library using serum prepared against a high molecular mass fraction of Fasciola hepatica excretory-secretory products. The full-length cDNA encodes a member of the recently described peroxiredoxin antioxidant family. Peroxiredoxin could be the major hydrogen peroxide removing antioxidant in F. hepatica since this parasite does not express a catalase and expresses little glutathione peroxidase activity. This novel antioxidant may be involved in functions such as protection against reactive oxygen species (ROS) generated by metabolic processes and/or protection of the parasite against ROS released by immune effector cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9226957     DOI: 10.1017/s0031182097001170

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  12 in total

Review 1.  Peroxiredoxins in parasites.

Authors:  Michael C Gretes; Leslie B Poole; P Andrew Karplus
Journal:  Antioxid Redox Signal       Date:  2012-01-25       Impact factor: 8.401

2.  Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages.

Authors:  Sheila Donnelly; Sandra M O'Neill; Mary Sekiya; Grace Mulcahy; John P Dalton
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 3.  Enzymatic antioxidant systems in helminth parasites.

Authors:  Lorena Chiumiento; Fabrizio Bruschi
Journal:  Parasitol Res       Date:  2009-05-22       Impact factor: 2.289

4.  Schistosome infection stimulates host CD4(+) T helper cell and B-cell responses against a novel egg antigen, thioredoxin peroxidase.

Authors:  D L Williams; H Asahi; D J Botkin; M J Stadecker
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

5.  An integrated transcriptomics and proteomics analysis of the secretome of the helminth pathogen Fasciola hepatica: proteins associated with invasion and infection of the mammalian host.

Authors:  Mark W Robinson; Ranjeeta Menon; Sheila M Donnelly; John P Dalton; Shoba Ranganathan
Journal:  Mol Cell Proteomics       Date:  2009-05-14       Impact factor: 5.911

6.  Survey of transcripts expressed by the invasive juvenile stage of the liver fluke Fasciola hepatica.

Authors:  Martín Cancela; Natalia Ruétalo; Nicolás Dell'Oca; Edileuza da Silva; Pablo Smircich; Gabriel Rinaldi; Leda Roche; Carlos Carmona; Fernando Alvarez-Valín; Arnaldo Zaha; José F Tort
Journal:  BMC Genomics       Date:  2010-04-07       Impact factor: 3.969

7.  Leucine aminopeptidase is an immunodominant antigen of Fasciola hepatica excretory and secretory products in human infections.

Authors:  A Marcilla; J E De la Rubia; J Sotillo; D Bernal; C Carmona; Z Villavicencio; D Acosta; J Tort; F J Bornay; J G Esteban; R Toledo
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

8.  Comparative characterization of microRNAs from the liver flukes Fasciola gigantica and F. hepatica.

Authors:  Min-Jun Xu; Lin Ai; Jing-Hua Fu; Alasdair J Nisbet; Qing-You Liu; Mu-Xin Chen; Dong-Hui Zhou; Xing-Quan Zhu
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

Review 9.  Novel Therapeutics for Multiple Sclerosis Designed by Parasitic Worms.

Authors:  Aakanksha Dixit; Akane Tanaka; Judith M Greer; Sheila Donnelly
Journal:  Int J Mol Sci       Date:  2017-10-13       Impact factor: 5.923

Review 10.  Fasciola hepatica-Derived Molecules as Regulators of the Host Immune Response.

Authors:  Sinéad Ryan; Jenna Shiels; Clifford C Taggart; John P Dalton; Sinéad Weldon
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.